Cecilia Otero an Oklahoma resident, is asking herself a lot of questions these days.

"Plan B, do I need to go and buy like, you know, a few to have on hand just in case? There's also the Plan C pill, and I'm just like, living in Oklahoma. I'm just like, well, how do I access that? And I don't know, like, my options feel very dwindled," Otero said.

At just shy of 32, she's made the call that she doesn’t want to have children. But in her home state of Oklahoma, she knows that should she get pregnant — she'd have some tough decisions to make.

"I feel like I don't have that right to choose anymore," Otero said.

And — she really doesn’t. Just about two months ago, Republican Governor Kevin Stitt signed a total abortion ban into law, enforced by civil lawsuits similar to the 2021 law upheld in Texas. It was just the latest in a string of anti-abortion bills in the state, but it’s the one that took care to a screeching halt.

Tamya Cox-Toure is the Executive Director at ACLU Oklahoma.

"Because of the fear of being sued with a $10,000 balance sheet, providers took the necessary steps in Oklahoma and stopped care on Friday when it went into effect," Cox-Toure said.

Abortion care facilities have been sitting vacant for more than a month — and even abortion care funds have been put on pause while lawyers figure out the legalities of the Supreme Court’s decision to overturn Roe.

"We have no idea what assist means. So people who may donate to our abortion fund, could they be in violation of these laws? People who help someone go to a state where abortion is legal, are they now in violation?" Cox-Toure said.

Oklahoma’s Attorney General John O’Connor on Friday that he believes the law is clear.

"I would say if you put up a billboard or if you advertise that that you're going to provide abortions in Oklahoma or in another state, that you're soliciting an abortion. So law enforcement is now activated with respect to any efforts to aid, abet, or solicit abortions," O’Connor said.

There are currently a handful of challenges in front of the state supreme court — dating back to 2017. But for now, their eyes are on Kansas — the only nearby state that permits abortion. But voters will weigh in there on a ballot initiative in August that could end that safe haven.

"We would be very much the, you know, abortion access desert because of where we are," Cox-Toure said.

Should it be successful — there may be an effort for a ballot initiative here, too. After all — a recent poll showed more than half of Oklahomans did not want to see a total ban.

Newsy is the nation’s only free 24/7 national news network. You can find Newsy using your TV’s digital antenna or stream for free. See all the ways you can watch Newsy here.

Walgreens and CVS plan to provide abortion pills following the Food and Drug Administrations rule change that broadens availability for the pills.

The Biden administration partially implemented the change last year, announcing it would no longer enforce a long-standing requirement that women pick up the medicine in person. Tuesday's action formally updates the drug's labeling to allow many more retail pharmacies to dispense the pills, so long as they complete a certification process.

In a statement, Walgreens said it intends to become a certified pharmacy under the program.

"We are working through the registration, necessary training of our pharmacists, as well as evaluating our pharmacy network in terms of where we normally dispense products that have extra FDA requirements and will dispense these consistent with federal and state laws," Walgreens stated.

The rule change’s impact has been blunted by numerous state laws limiting abortion broadly and the pills specifically. Legal experts foresee years of court battles over access to the pills, as abortion-rights proponents bring test cases to challenge state restrictions.

CVS said it plans to seek certification after reviewing the FDA's updated Risk Evaluation and Mitigation Strategy drug safety program for mifepristone, the generic name of the drug.

"We plan to seek certification to dispense mifepristone where legally permissible following that review," CVS said in a statement.

For more than 20 years, the FDA labeling had limited dispensing to a subset of specialty offices and clinics, due to safety concerns. During the COVID-19 pandemic, the FDA temporarily suspended the in-person requirement. The agency later said a new scientific review by agency staff supported easing access, concurring with numerous medical societies that had long said the restriction wasn't necessary.

Two drugmakers that make brand-name and generic versions of abortion pills requested the latest FDA label update. Agency rules require a company to file an application before modifying dispensing restrictions on drugs.

Danco Laboratories, which sells branded Mifeprex, said in a statement the change “is critically important to expanding access to medication abortion services and will provide healthcare providers” with another option for prescribing the drug.

The American College of Obstetricians and Gynecologists called the update an “important step" forward.

“Although the FDA’s announcement today will not solve access issues for every person seeking abortion care, it will allow more patients who need mifepristone for medication abortion additional options to secure this vital drug,” the group said in a statement.

More than half of U.S. abortions are now done with pills rather than surgery, according to the Guttmacher Institute, a research group that supports abortion rights.

The FDA in 2000 approved mifepristone to terminate pregnancies of up to 10 weeks, when used with a second drug, misoprostol. Mifepristone is taken first to dilate the cervix and block the hormone progesterone, which is needed to sustain a pregnancy. Misoprostol is taken 24 to 48 hours later, causing the uterus to contract and expel pregnancy tissue.

Bleeding is a common side effect, though serious complications are very rare. The FDA says more than 3.7 million U.S. women have used mifepristone since its approval.

Several FDA-mandated safety requirements remain in effect, including training requirements to certify that prescribers can provide emergency care in the case of excessive bleeding. Pharmacies that dispense the pills also need a certification.